All companies
Visit website
BIOPHYSICAL THERAPEUTICS, INC.
OperatingBiophysical Therapeutics, Inc.
Healthcare · Biotech · Founded 2022
Immigrant-foundedVeteran-founded
Trying to develop a drug to slow aging
Valuation cap ⓘ
$6.5M
As of Apr 2024 · from BIOPHYSICAL THERAPEUTICS, INC. Future Equity SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$163,040
Across 2 rounds since 2023
Latest share price
$1.00
Reg CF Offering (2026) offering price
Financials
FY2021–FY2025 · from SEC filings · hover any figure for its source$0
2021
$0
2022
$0
−$83K
2024
$0
−$67K
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021
FY2022
FY2024
FY2025
Income statement
Revenue
$0
$0
$0
$0
Cost of goods sold
$0
$0
$0
$0
Net income
$0
$0
-$82,802
-$66,936
Taxes paid
$0
$0
$0
$0
Balance sheet
Cash
$0
$90
$52,288
$40,500
Accounts receivable
$0
$0
$0
$0
Total assets
$0
$90
$52,288
$40,500
Short-term debt
$0
$0
$0
$0
Long-term debt
$0
$0
$0
$0
Total liabilities
$0
$0
$0
$0
Other
Headcount
—
1
—
1
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$6.5M
Valuation cap
BIOPHYSICAL THERAPEUTICS, INC. Future Equity SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $59.6K / $124KInvestors 119Valuation cap $6.5M
Reg CF annual-report compliance
Not requiredFiled Form C-TR (terminated reporting)
Filed 1 of 3 annual reports (FY2023–FY2025)
119 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001980213Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.